Pfizer CEO: “Very High Level of Confidence” that the Covid Treatment Pill Is Effective Against the Omicron Variant

Pfizer CEO Albert Bourla said he expects the company’s Covid-19 treatment pill to be effective against the omicron variant of the virus causes Covid-19.

The good news when it comes to our treatment, it was designed with that in mind, it was designed with the fact that most mutations are coming in the spikes,” Bourla explained.  “So that gives me very high level of confidence that the treatment will not be affected, our oral treatment will not be affected by this virus.”

Pfizer submitted its application earlier this month to the Food and Drug Administration (FDA) to authorize the pill, Paxlovid, for emergency use. In a clinical trial of people age 18 and over, Pfizer found the pill reduces hospitalization and death by 89% when taken with a widely used HIV drug within three days of the start of symptoms. The pill blocks an enzyme the virus needs to replicate. It is used in combination with HIV drug ritonavir, which slows the human metabolism to allow the Paxlovid to remain active in the body longer at a higher concentration to combat the virus.

https://www.cnbc.com/

Covid: Pfizer Says Antiviral Pill 89% Effective in High-Risk Cases

An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest. The drugPaxlovid – is intended for use soon after symptoms develop in people at high risk of severe diseaseIt comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp and Dohme (MSD).

Pfizer says it stopped trials early as the initial results were so positiveThe UK has already ordered 250,000 courses of the new Pfizer treatment, along with another 480,000 courses of MSD‘s molnupiravir pillHealth and Social Care Secretary Sajid Javid called the results “incredible”, and said the UK’s medicines regulator would now assess its safety and effectiveness.

If approved, this could be another significant weapon in our armoury to fight the virus alongside our vaccines and other treatments,” he said.

The Pfizer drug, known as a protease inhibitor, is designed to block an enzyme the virus needs in order to multiply. When taken alongside a low dose of another antiviral pill called ritonavir, it stays in the body for longer.

Three pills are taken twice a day for five days.

Source: https://www.bbc.com/